Ajooni Biotech Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Jasjot Singh, was filed 31 Dec 2025.
Ajooni Biotech Limited: what insiders have been doing
Ajooni Biotech Limited, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEBI (PIT + SAST). Between 8 November 2025 and 8 November 2026, 3 insiders published 6 filings.
The record shows 2 purchases on the open market worth €0, made by 2 insiders, against 1 sale worth €0 by 1 insider. Netting one side against the other leaves €0 of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. One trade stands out by size: a purchase of €0 from parmjeet Kaur, disclosed on 23 December 2025. On the buying side, the filings list 2 major shareholders among the declarants.
With 6 filings in twelve months, the company is more active than the median of 4 filings across the 1,985 companies we follow on the same exchange. Looking back to 2021, when coverage begins, insiders filed 7 purchases and 78 sales.
The last insider purchase was made public on 23 December 2025, 320 days ago. Typically, a trade is published a median of 1 day after it takes place. This delay matters because a trade only becomes useful information once it is public.
In the same sector, recent insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. also feature in our signals. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- -30.5%Entry ₹4.33 · Close 13 Oct 2026 ₹3.01
- -30.5%Entry ₹4.33 · Close 13 Oct 2026 ₹3.01
- -23.1%Entry ₹8.29 · Close at T+365 ₹6.38
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 12,112,174 shares@ ₹4.20100.0% of flowEquity SharesSEBI:c460cfd9be510d1a30083e000f099f497123df09
- 2,112,174 shares@ ₹4.20100.0% of flowEquity SharesSEBI:6a9766c590fdfe0f7fb00b6e3b4057ccdfc60ad9Canonical exit: 30 Mar 2026 (T+90)
- 10,000,000 shares@ ₹4.20100.0% of flowEquity SharesSEBI:fce4cc6253b82b4e7e7721572a64ddebb7da8b8bCanonical exit: 30 Mar 2026 (T+90)
- 2,112,174 shares0.0% of flowEquity SharesSEBI:d7ab1dc21c00a3fd26482a1ba0af4bb08075fe64Canonical exit: 23 Mar 2026 (T+90)
- 10,000,000 shares0.0% of flowEquity SharesSEBI:05ceb51fc7aa72759b107ce37d19b12c55ad92adCanonical exit: 23 Mar 2026 (T+90)
- 12,112,174 shares0.0% of flowEquity SharesSEBI:ac6458d08b28eb4a26f65293386b38423313e6b5
- 200,000 shares@ ₹4.5039.2% of flowEquity SharesSEBI:a25cf0b5d40d16333e2288e87dc536e6a76713d8
- 300,000 shares@ ₹4.5022.9% of flowEquity SharesSEBI:b7ae24234cc32144d554edbca0b7461243ebab8e
- 400,000 shares@ ₹4.529.0% of flowEquity SharesSEBI:dc96494ead1627aca0c6670bb012e09a765f4254
- 290,000 shares@ ₹4.8360.7% of flowEquity SharesSEBI:41b2024fd8da7799ad6be36666b103305e1a0e31
- 381,803 shares@ ₹4.919.3% of flowEquity SharesSEBI:08b61fdfe43be2570f20a8cdd3884511e5cb390c
- 210,000 shares@ ₹4.985.1% of flowEquity SharesSEBI:ea4b2363535179dac036f1cd320059b68cad74d4
- 100,000 shares@ ₹4.818.1% of flowEquity SharesSEBI:32c8b8e11069ff6b0a90445d29fe63e489718c47
- 136,583 shares@ ₹4.753.2% of flowEquity SharesSEBI:0f0f0ae5760943fd64c2806e09eb53eb0dbdfb28
- 338,609 shares@ ₹4.828.1% of flowEquity SharesSEBI:12a6d7d16a1e0c62537d05cb6a08df987b1de9be
- 400,000 shares@ ₹5.1510.1% of flowEquity SharesSEBI:0b6aff58b9ec4d9d05fc88984c40e20281ac0759
- 400,000 shares@ ₹4.689.2% of flowEquity SharesSEBI:0266b8154351f17c7aa1a03cc7e910daca43fc63
- 217,718 shares@ ₹4.4016.1% of flowEquity SharesSEBI:b3fca7e7da54eaab4c879be2d22e47fcd94e790a
- 171,342 shares@ ₹4.353.6% of flowEquity SharesSEBI:9df48be0ca611f7d23ff6c21fda9897d755ca5e9
- 400,000 shares@ ₹4.659.1% of flowEquity SharesSEBI:34105740a71c8f268b447e2013dd1859065adc08
- 54,491 shares@ ₹4.604.2% of flowEquity SharesSEBI:c17940319b9e90d42199bc556245911c6e8a78a2
- 189,368 shares@ ₹4.754.4% of flowEquity SharesSEBI:68471b2db9afd67732bfc10905a7ed5755858382
- 50,000 shares@ ₹4.804.0% of flowEquity SharesSEBI:09bcb7e36dcddce069811984f8a3891da7a1fc81
- 40,893 shares@ ₹4.803.3% of flowEquity SharesSEBI:586daa47ba02aea81395e6f51a76a640997a4a8f
- 400,000 shares@ ₹4.759.4% of flowEquity SharesSEBI:e2878987a8dbeb0d07ae959d9de92e1e7e893101
25 of 85 declarations
About Ajooni Biotech Limited
Ajooni Biotech Limited is a company focused on the healthcare and pharmaceutical sector. It is listed on the XBOM.
